Answers are grounded in this paper and cite their sources.
The risk of thromboembolic pathologies increases in COVID-19 cases who have risk factors for poor prognosis and are prone to have a severe clinical course. Few cases of cerebral sinus vein thrombosis (CSVT) accompanying COVID-19 have been reported. We present a patient who developed CSVT during COVID-19 without a known risk factor for thrombosis but was found to have a genetic mutation of the prothrombin 20210 G/A gene, which is a congenital thrombophilia risk factor. We aim to emphasize the importance of investigating additional pathologies in thromboembolic events during COVID-19 in cases without known comorbidities.
No takes yet. Share an insight, caveat, or question.
Örmen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: